×

Analysis of Transcriptomic Data Using Similarity Based Modeling

  • US 20110093244A1
  • Filed: 07/13/2010
  • Published: 04/21/2011
  • Est. Priority Date: 04/13/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method for discovery of biomarkers indicative of a medical condition in a species of organism, from a candidate set of molecular constituents extracted from such organisms, comprising the steps of:

  • determining a set of molecular constituents to test as biomarkers;

    obtaining first measurements of the quantity of each of the molecular constituents present in each of a first plurality of samples extracted from such organisms free of the condition;

    training and storing in a computer memory, a kernel-based estimation model using said first measurements as multivariate training observations, each multivariate observation comprising the measurements from a single condition-free sample;

    obtaining second measurements of the quantity of each of the molecular constituents present in each of a second plurality of samples extracted from such organisms free of the condition;

    obtaining third measurements of the quantity of each of the molecular constituents present in each of a third plurality of samples extracted from such organisms having the medical condition;

    estimating with said model, using a microprocessor, an estimated quantity for each of at least some of the molecular constituents in a sample, responsive to inputting to said model a multivariate input observation comprising the measurements from that sample, for all of said second plurality of samples and all of said third plurality of samples;

    computing residuals corresponding to at least one molecular constituent, each residual being the difference between an estimated quantity of that molecular constituent for a sample and the measured quantity of that molecular constituent for that sample; and

    comparing, for at least one molecular constituent, residuals from said second plurality of samples with residuals from said third plurality of samples, to identify whether that molecular constituent is a biomarker of said medical condition.

View all claims
  • 7 Assignments
Timeline View
Assignment View
    ×
    ×